Company Number: 13411325

Analysis Date: 2025-07-20 16:06 UTC

Financial Health Assessment of MDL 1967 LIMITED

---

1. Financial Health Score: A-

Explanation:
MDL 1967 LIMITED demonstrates strong financial stability and asset growth, highlighted by a robust equity base and positive working capital. The company exhibits signs of healthy financial "vital signs," with a solid asset structure and prudent management of liabilities. Minor concerns about liquidity reduction warrant monitoring but do not currently impair overall financial wellness.

---

2. Key Vital Signs

Metric	2023 Value	Interpretation
Net Assets (Equity)	£3,839,453	Strong equity position indicating good "financial muscle".
Fixed Assets	£3,634,964	Majority are investments and property; stable, long-term asset base.
Current Assets	£267,360	Includes cash and debtors; decreased significantly from prior year.
Cash at Bank	£201,701	Healthy cash reserve, though reduced by ~60% from 2022, indicating cash outflow or investment.
Current Liabilities	£36,914	Low short-term obligations relative to assets.
Net Current Assets (Working Capital)	£230,446	Positive working capital, indicating ability to cover short-term debts.
Deferred Tax Provision	£25,957 (liability)	Small deferred tax liability, typical for investment-related gains.
Profit & Loss Account (Retained Earnings)	£3,839,403	Accumulated profits signify consistent value creation.
Revenue Source	Rental income, investments, dividends	Stable income streams from diversified investment portfolio.

---

3. Diagnosis: Financial Condition Overview

MDL 1967 LIMITED exhibits the "healthy heartbeat" of a well-capitalized investment holding company. Its balance sheet "pulse" shows significant growth in fixed assets—mainly investments—rising from £2.42m in 2022 to £3.63m in 2023, reflecting active asset acquisition and portfolio expansion.

The company’s liquidity "vital signs" remain positive with net current assets of £230k, ensuring short-term obligations are comfortably met. However, the reduction in current assets and cash reserves compared to the prior year suggests cash has been deployed into longer-term assets or used for operational purposes. This is not immediately alarming but warrants prudent cash flow management to avoid potential liquidity "symptoms" in the future.

The low level of current liabilities and absence of long-term debt highlight a conservative financial structure, reducing risk of "financial distress" from leverage. Deferred tax provision is modest and reflects normal timing differences related to investment gains.

The company is in a "stable health" state with strong equity and retained earnings, indicating sustained profitability or capital appreciation. The going concern assumption is supported by the director, and no adverse events such as overdue filings, disqualifications, or legal encumbrances are present.

---

4. Recommendations: Improving Financial Wellness

• Maintain Liquidity Vigilance:
  Given the reduction in cash and current assets, ensure ongoing cash flow forecasting to maintain a "healthy circulation" of funds for operational needs and unforeseen expenses.

• Diversify Investment Portfolio:
  While investment growth is positive, consider diversification to mitigate risk. Monitor impairments closely, as seen with a £12k charge in 2023, to prevent "silent infections" in asset value.

• Periodic Asset Valuation:
  Continue regular fair value assessments of investment properties and securities to detect early signs of value erosion or opportunity.

• Enhance Revenue Streams:
  Explore additional income avenues or enhance existing investment income to strengthen "nutritional intake" for the company’s financial health.

• Governance and Compliance:
  Maintain timely filings and governance standards to avoid penalties or administrative strain, ensuring the company remains in "healthy compliance."

• Contingency Planning:
  Develop contingency plans for liquidity crunch scenarios, preserving resilience against market volatility or unexpected outflows.

---

Executive Summary